Clinical Trial Detail

NCT ID NCT03791398
Title BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (379)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Khaldoun Almhanna
Indications

colorectal cancer

Therapies

Nivolumab + ONC201

Age Groups: senior adult

No variant requirements are available.